This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,659 Years Active: 2010
Title: Chang-Gu Hyun: Innovator in Enzyme Biosynthesis
Introduction
Chang-Gu Hyun is a notable inventor based in Yongin, South Korea. He has made significant contributions to the field of biotechnology, particularly in the area of enzyme biosynthesis. His work focuses on the development of methods that enhance the production of valuable secondary metabolites.
Latest Patents
Chang-Gu Hyun holds 1 patent. His patent discloses an isolated nucleotide sequence that encodes an enzyme responsible for catalyzing the biosynthesis of S-adenosylmethionine (SAM). This invention also provides a method for the mass production of useful secondary metabolites, including antibiotics, utilizing the isolated nucleotide sequence and SAM, where SAM serves as a methyl group donor.
Career Highlights
Throughout his career, Chang-Gu Hyun has demonstrated a commitment to advancing biotechnological innovations. His research has implications for the pharmaceutical industry, particularly in the development of antibiotics and other therapeutic agents.
Collaborations
Chang-Gu Hyun has collaborated with notable colleagues, including In-Hyung Lee and Joo-Won Suh. These partnerships have contributed to the advancement of his research and the successful application of his inventions.
Conclusion
Chang-Gu Hyun is a distinguished inventor whose work in enzyme biosynthesis has the potential to impact various industries. His innovative approaches to producing secondary metabolites highlight the importance of biotechnology in modern science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile